Business Context and Reporting Period
Company: Mannatech, Inc. (MTEX)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2026
Business Overview: Mannatech develops and sells nutritional supplements, skin care, and weight-management products primarily through a network marketing channel of independent associates and preferred customers. Operations span the Americas, EMEA, and Asia/Pacific regions, with a non-direct selling e-commerce subsidiary in China.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Sales | $24.9 million | $26.6 million |
| Gross Profit | $18.9 million | $19.7 million |
| Gross Margin | 75.7% | 74.3% |
| Operating Loss | $(0.2) million | $(0.8) million |
| Net Income (Loss) | $0.95 million | $(1.53) million |
| Diluted EPS | $0.49 | $(0.80) |
| Cash and Cash Equivalents | $7.0 million | $10.4 million (Q1 2025 end) |
| Working Capital | $1.7 million | $1.8 million (Dec 31, 2025) |
| Total Debt (Notes Payable) | $3.1 million | $2.8 million (Dec 31, 2025) |
Cash Flow: Net cash provided by operating activities was $1.1 million for Q1 2026, compared to a use of $1.4 million in Q1 2025. Investing activities used $0.1 million, and financing activities used $0.1 million.
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 6.2% year-over-year to $24.9 million. On a constant dollar basis (excluding currency effects), sales decreased 8.1%. The decline was driven by slowing demand, particularly in the Americas region, which saw a 25.6% drop in sales.
- Profitability Turnaround: The company reported a net income of $0.95 million, a significant improvement from a net loss of $1.53 million in Q1 2025. This turnaround was primarily driven by a $1.4 million foreign exchange gain (compared to a $0.4 million loss in the prior year) and reduced operating expenses.
- Expense Reduction: Total operating expenses decreased 7.4% to $19.0 million. Selling and administrative expenses dropped 7.3% due to reductions in office expenses, legal fees, and payroll.
- Associate Base: The number of active associates and preferred customers decreased by 17.1% in the Americas, while the Asia/Pacific region saw a 14.8% decrease in active associates, partially offset by a 21.3% increase in revenue per associate.
Guidance, Outlook, Risks, and Contingencies
Liquidity and Going Concern
Management has disclosed conditions that raise substantial doubt about the Company's ability to continue as a going concern within one year. These conditions include historical declines in net sales, operating losses, and negative cash flows in the prior year. To address this, management has implemented:
- Capital Discipline: Suspension of non-essential capital expenditures for fiscal year 2026.
- Cost Reduction: Comprehensive cost-cutting, including headcount reductions and conversion of director compensation to equity (expected to save ~$0.8 million annually).
- Margin Initiatives: Targeted pricing actions and supply chain optimization.
Nasdaq Compliance Risk
On April 20, 2026, the Company received notice from Nasdaq that it is not in compliance with Listing Rule 5550(b)(1) regarding minimum stockholders' equity ($2.5 million). The Company currently has negative shareholders' equity of $(5.6) million. Management is evaluating options to regain compliance, including capital-raising transactions, but there is no assurance of success.
Operational Risks
- Trade Policy: Exposure to tariffs and trade disputes affecting supply chain costs and profitability.
- System Remediation: The Company is addressing order-processing system issues in North America that caused an estimated $6.0 million revenue loss in 2025.
- Foreign Currency: Significant exposure to currency fluctuations, which contributed to the Q1 2026 net income via a $1.4 million unrealized gain.
Investor Verification Checklist
- Going Concern Status: Verify the effectiveness of the cost-cutting plan and whether it will be sufficient to generate positive operating cash flow consistently.
- Nasdaq Compliance Plan: Monitor the Company's submission of a compliance plan to Nasdaq and the likelihood of regaining minimum stockholders' equity.
- Revenue Sustainability: Assess whether the 6.2% revenue decline is a temporary fluctuation or a structural trend, particularly given the 17.1% drop in active associates in the Americas.
- Debt Obligations: Review the terms of the $3.1 million in notes payable (16% interest rate) and the maturity extensions to September 2027.
- Foreign Exchange Impact: Determine the extent to which Q1 2026 profitability was driven by non-operating foreign exchange gains rather than core operational improvements.